Total Views : 2,171 , Today Views : 6
Hybridoma Technology is a method for producing large numbers of identical antibodies (also called monoclonal antibodies). This process starts by injecting a mouse (or other mammal) with an antigen that provokes an immune response. A type of white blood cell, the B cell that produces antibodies that bind to the antigen are then harvested from the mouse. These isolated B cells are in turn fused with immortal B cell cancer cells, a myeloma, to produce a hybrid cell line called a Hybridoma, which has both the antibody-producing ability of the B-cell and the exaggerated longevity and reproductively of the myeloma.
Hybridoma Technology Seminar Report
Page Length : 13
- In Diagnostic Histopathology
Hybridoma Technology Presentation Report (PPT)
Page Length : 17
- Purification of Antibodies